Results 181 to 190 of about 3,800,890 (227)
Some of the next articles are maybe not open access.

Piquing artificial intelligence towards drug discovery: Tools, techniques, and applications

Drug development research (Print)
The purpose of this study was to discuss how artificial intelligence (AI) methods have affected the field of drug development. It looks at how AI models and data resources are reshaping the drug development process by offering more affordable and ...
P. Agu, Chidiebere Nwiboko Obulose
semanticscholar   +1 more source

Bienzymatic synergism of vanadium oxide nanodots to efficiently eradicate drug-resistant bacteria during wound healing in vivo.

Journal of Colloid and Interface Science, 2020
Weishuai Ma   +7 more
semanticscholar   +1 more source

Synergizing drug repurposing and target identification for neurodegenerative diseases

Despite dedicated research efforts, the absence of disease-curing remedies for neurodegenerative diseases (NDDs) continues to jeopardize human society and stands as a challenge. Drug repurposing is an attempt to find new functionality of existing drugs and take it as an opportunity to discourse the clinically unmet need to treat neurodegeneration ...
Mehar, Sahu   +6 more
openaire   +2 more sources

Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies

Ca-A Cancer Journal for Clinicians, 2022
Paolo Tarantino   +2 more
exaly  

Cancer epigenetics in clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Veronica Davalos, Manel Esteller
exaly  

Synergism with GABAergic drugs in refractory epilepsy

The Lancet, 1994
MartinJ. Brodie, John Paul Leach
openaire   +2 more sources

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel   +2 more
exaly  

A story of metformin‐butyrate synergism to control various pathological conditions as a consequence of gut microbiome modification: Genesis of a wonder drug?

Pharmacological Research, 2017
Kunal Maniar   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy